Merck KGAA (PK) Quote - MKGAF

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

154.49

Bid

147.65

Offer

155.25

Volume

237

148.41 Day's Range 154.49

140.005 52 Week Range 200.56

Market Cap

19.967B

Previous Close

149.50

Open

152.111

Last Trade

191

154.49

Last Trade Time

05:05:17

Financial Volume

US$ 36,563

VWAP

154.2736

Average Volume (3m)

994

Shares Outstanding

129,242,251

Dividend Yield

1.37%

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

20.99B

Net Profit

2.82B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.merck.de

Headquarters

Darmstadt, Deu

Founded

1987

Merck KGAA (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MKGAF. The last closing price for Merck KGAA (PK) was US$149.50. Over the last year, Merck KGAA (PK) shares have traded in a share price range of US$ 140.005 to US$ 200.56.

Merck KGAA (PK) currently has 129,242,251 shares in issue. The market capitalisation of Merck KGAA (PK) is US$19.32 billion.

Data on Merck KGaA's L-BLP25 - Analyst Blog

Merck KGaA (MKGAF ) recently presented detailed results on its oncology candidate L-BLP25, from the phase III study, START (Stimulating Targeted Antigenic Responses To NSCLC). Results...

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog

Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the reported quarter were up 4.4% year over year...

Merck KGaA-CBRX Renew Agreement - Analyst Blog

Merck KGaA (MKGAF) and Columbia Laboratories, Inc. (CBRX) recently renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years. This...

Sanofi Reports Lemtrada Data - Analyst Blog

Sanofi’s (SNY) subsidiary, Genzyme, recently announced interim data on its multiple sclerosis (MS) candidate, Lemtrada (alemtuzumab), from the first year of an extension study. ...

Merck KGaA-BMY Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a deal with Bristol-Myers Squibb (BMY) for the promotion of different formulations of Glucophage (metformin hydrochloride) in China. Glucophage is used for...

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin (recombinant human FGF-18). Sprifermin is being...

Threshold Cuts Loss, Misses Sales - Analyst Blog

Threshold Pharmaceuticals Inc. (THLD) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss of 11...

Strong Quarter for Merck KGaA - Analyst Blog

Merck KGaA (MKGAF) reported fourth quarter 2012 earnings per American Depository Receipt (ADR) of $2.66, up 18.8% year over year. Revenues for the reported quarter were up 8% year over year...

Positive Data from BMRN's PKU-016 - Analyst Blog

BioMarin Pharmaceutical Inc. (BMRN) recently announced positive results from the PKU-016 ASCEND study. This is the largest randomized controlled study evaluating the safety and therapeutic...

Threshold/Merck KGaA Drug in Study - Analyst Blog

Threshold Pharmaceuticals, Inc. (THLD) and Merck KGaA (MKGAF) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302. The study...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	6.617	4.47478579592	147.873	154.49	144.67	328	147.35397411	CS
4	6.445	4.35340605897	148.045	154.49	140.005	1805	145.81357837	CS
12	-7.075	-4.37904249064	161.565	171.67	140.005	994	146.3550325	CS
26	-17.495	-10.1723987557	171.985	200.56	140.005	551	152.11429774	CS
52	-6.81	-4.2219466832	161.3	200.56	140.005	538	161.32884499	CS
156	-60.81	-28.2443102647	215.3	229.84	140.005	665	169.92368179	CS
260	24.79	19.1133384734	129.7	264.4	82	628	157.68497955	CS

MKGAF - Frequently Asked Questions (FAQ)

What is the current Merck KGAA (PK) share price?

The current share price of Merck KGAA (PK) is US$ 154.49

How many Merck KGAA (PK) shares are in issue?

Merck KGAA (PK) has 129,242,251 shares in issue

What is the market cap of Merck KGAA (PK)?

The market capitalisation of Merck KGAA (PK) is USD 19.32B

What is the 1 year trading range for Merck KGAA (PK) share price?

Merck KGAA (PK) has traded in the range of US$ 140.005 to US$ 200.56 during the past year

What is the reporting currency for Merck KGAA (PK)?

Merck KGAA (PK) reports financial results in EUR

What is the latest annual turnover for Merck KGAA (PK)?

The latest annual turnover of Merck KGAA (PK) is EUR 20.99B

What is the latest annual profit for Merck KGAA (PK)?

The latest annual profit of Merck KGAA (PK) is EUR 2.82B

What is the registered address of Merck KGAA (PK)?

The registered address for Merck KGAA (PK) is FRANKFURTER STRASSE 250, DARMSTADT, 64293

What is the Merck KGAA (PK) website address?

The website address for Merck KGAA (PK) is www.merck.de

Which industry sector does Merck KGAA (PK) operate in?

Merck KGAA (PK) operates in the PHARMACEUTICAL DIVERSIFIED sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MITJFMint Corporation (CE)	US$ 0.01 (999,900.00%)	1.5k
MHPCManufactured Housing Properties Inc (CE)	US$ 0.0003 (29,900.00%)	800
ONCIOn4 Communications Inc (PK)	US$ 0.0002 (19,900.00%)	11.65M
GNRSQGreenrose Holding Company Inc (CE)	US$ 0.02 (19,900.00%)	10.2k
KBNTKubient Inc (CE)	US$ 0.0002 (19,900.00%)	1.7k
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0.000001 (-99.99%)	539
PKLBFPerk Labs Inc (CE)	US$ 0.000001 (-99.97%)	23.59k
EVRRFMolecule Holdings Inc (CE)	US$ 0.000001 (-99.96%)	30.58k
ELYSElys BMG Group Inc (CE)	US$ 0.000001 (-99.75%)	895
GXXMGex Management Inc (CE)	US$ 0.000001 (-99.00%)	1.68k
HMBLHUMBL Inc (PK)	US$ 0.0008 (0.00%)	197.23M
MMEXMMEX Resources Corporation (PK)	US$ 0.0001 (0.00%)	126.83M
GTVHGolden Triangle Ventures Inc (PK)	US$ 0.0003 (0.00%)	118.49M
PDGOParadigm Oil and Gas Inc (PK)	US$ 0.000001 (-99.00%)	92.23M
GRLTGrillit Inc (PK)	US$ 0.0005 (-16.67%)	67.08M